Telligent Fund LP Makes New $1.57 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Telligent Fund LP bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,000 shares of the medical equipment provider’s stock, valued at approximately $1,566,000. Intuitive Surgical comprises 1.5% of Telligent Fund LP’s portfolio, making the stock its 21st biggest position.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter valued at $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the third quarter valued at $38,000. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on ISRG shares. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Mizuho increased their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Down 0.4 %

ISRG opened at $588.50 on Friday. The firm has a market capitalization of $209.61 billion, a PE ratio of 91.81, a P/E/G ratio of 5.51 and a beta of 1.39. The firm has a 50 day moving average of $553.03 and a two-hundred day moving average of $512.59. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Activity

In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock valued at $3,333,485 in the last three months. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.